Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Immunovant Inc
About IMVT
Immunovant, Inc. is a clinical-stage immunology company enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-fragment crystallizable receptor (FcRn) technology, the Company is developing targeted therapies to meet the complex and variable needs of people with autoimmune diseases. Its product pipeline includes its product candidates, IMVT-1402 and batoclimab, both of which are novel, fully human, monoclonal antibodies that target the neonatal FcRn. Subcutaneous injections, IMVT-1402 and batoclimab have been observed to reduce immunoglobulin G (IgG) antibody levels, which has provided evidence supporting the use of an anti-FcRn antibody in disease areas associated with high levels of pathogenic IgG antibodies. The Company is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD).
Find out what a historical investment in Immunovant Inc would be worth today using our IMVT stock calculator.
Market Capitalisation
$5.35B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
19.57M
High today
$36.29
Low today
$30.10
Open price
$30.44
52-week high
$30.16
52-week low
$13.79
Ready to start your investing journey with Stake?
Open an accountHow do I buy IMVT shares in Australia?
Buying IMVT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Immunovant Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IMVT
What is the ticker symbol of Immunovant Inc?
The ticker symbol for Immunovant Inc is IMVT.
How much is one share of IMVT?
One share of IMVT is valued at $35.60 as of 20 May 2026.
What is the market capitalisation of Immunovant Inc IMVT?
As of 20 May 2026 Immunovant Inc has a market cap of $5.35B.
What is the 52-week high for Immunovant Inc stock?
The Immunovant Inc 52-week high stock price is $30.16.
What is the 52-week low for Immunovant Inc stock?
The Immunovant Inc 52-week low stock price is $13.79.
Can I buy IMVT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IMVT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IMVT on Stake
- Buy IMVT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of IMVT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
IMVT related stocks